Overview
To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.
Description
Patients will be followed up for 3 years as standard of care.
Eligibility
Inclusion Criteria:
- Primary diagnosis of Benign Prostate Hypertrophy (BPH)
- Male subjects of ≥ 18 years of age
- Candidate for Aquablation therapy as per clinical decision of Investigator
- Willing and able to accurately complete questionnaires
- Willing and able to provide signed and dated informed consent
Exclusion Criteria:
- Characteristics indicating a poor compliance with study protocol requirements.
- Disease or other health condition that is not suitable for this study.
- Unable or unwilling to provide signed informed consent.